Evidence map›Paper›PMID 40705030›Full record

ArticleDiabetes2025

Loss of Insulin-Positive Cell Clusters Precedes the Decrease in Islet Frequency and β-Cell Area in Type 1 Diabetes.

Denise M Drotar, Giovanni J A Vazquez Ramos, MacKenzie D Williams, Surya T David, Caitlyn Luce, Justin A Smith, Amanda L Posgai, Rhonda Bacher, Martha Campbell-Thompson, Irina Kusmartseva and 3 more

Abstract read
In one paragraph

Article in Diabetes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Denise M DrotarDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida Diabetes Institute, Gainesville, FL.
Giovanni J A Vazquez RamosDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida Diabetes Institute, Gainesville, FL.
MacKenzie D WilliamsDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida Diabetes Institute, Gainesville, FL.
Surya T DavidDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida Diabetes Institute, Gainesville, FL.
Caitlyn LuceDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida Diabetes Institute, Gainesville, FL.
Justin A SmithDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida Diabetes Institute, Gainesville, FL.
Amanda L PosgaiDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida Diabetes Institute, Gainesville, FL.
Rhonda BacherDepartment of Biostatistics, University of Florida, Gainesville, FL.
Martha Campbell-ThompsonDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida Diabetes Institute, Gainesville, FL.
Irina KusmartsevaDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida Diabetes Institute, Gainesville, FL.
Maigan A BruskoDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida Diabetes Institute, Gainesville, FL.
Mark A AtkinsonDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida Diabetes Institute, Gainesville, FL.
Clive H WasserfallDepartment of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida Diabetes Institute, Gainesville, FL.ORCID 0000-0002-3522-8932

Funding

Project 3P01AI042288 · NIAID · UNIVERSITY OF FLORIDA · PI Todd Michael Brusko · 1997 to 2026
$32.9M
Survival and potential of insulin-deficient beta cells in type 1 diabetesU01DK135001 · NIDDK · UNIVERSITY OF FLORIDA · PI SCHATZ, DESMOND ARTHUR · 2022 to 2025
$2.8M
Co-registration of Cell Organization, Phenotype and Function in the Human Pancreas During Type 1 DiabetesR01DK131059 · NIDDK · UNIVERSITY OF FLORIDA · PI ATKINSON, MARK A. · 2021 to 2025
$2.5M
Resolving single-cell analysis challenges via data-driven decision frameworks and novel statistical methodsR35GM146895 · NIGMS · UNIVERSITY OF FLORIDA · PI Rhonda Bacher · 2022 to 2026
$1.9M
Regional and lobular heterogeneity of human pancreas morphology and function in type 1 diabetes pathogenesisR01DK123292 · NIDDK · UNIVERSITY OF FLORIDA · PI ATKINSON, MARK A., SPEIER, STEPHAN · 2020 to 2023
$1.7M
Breakthrough-T1D 3-PDF-2025-1675-A-NBreakthrough-T1D Grant#3-SRA-2023-1417-S-BNIAID NIH HHS P01 AI042288NIDDK NIH HHS R01 DK123292NIDDK NIH HHS R01 DK131059NIDDK NIH HHS U01 DK135001NIGMS NIH HHS R35 GM146895The Leona M. & Harry B. Helmsley Charitable Trust
6 · The paper itself

Abstract

In type 1 diabetes (T1D), insulin (INS) deficiency results from immune-mediated destruction of β-cells. The majority of functional β-cell mass is typically lost within months to years of disease diagnosis, but the timing and nature of this loss, particularly in early disease stages, remain unclear. We developed a whole-slide scanned image analysis pipeline for semiautomated quantitation of endocrine area, islet frequency, interislet distance, and endocrine object size distribution in 145 human pancreata from 60 donors without diabetes, 19 donors with single autoantibody positivity, 10 with multiple autoantibody positivity (mAAb+), 16 with recent-onset T1D (duration 0-1 year), 23 with medium-duration T1D (1-7 years), and 17 with long-duration T1D (≥7 years). We observed age-related differences in endocrine composition and islet frequency in pancreata from donors without diabetes. Age-corrected data revealed decreased islet frequency and greater interislet distance in the T1D pancreas. INS+ single cells (≤10 μm), cell clusters (>10 to <35 μm), and small- and medium-sized islets (35-100 and 100-200 μm, respectively) were significantly lost at T1D onset, whereas large INS+ islets (>200 μm) were preserved. Moreover, changes in endocrine composition also occurred in pancreata from mAAb+ donors, including a significant decrease in the INS+ islet fraction. These data suggest preferential loss of INS+ small endocrine objects early in T1D development. ARTICLE HIGHLIGHTS: Understanding the timing and nature of β-cell loss is essential for developing effective strategies to interrupt type 1 diabetes progression. Which types of islets, in terms of size and cellular composition, are lost first during disease development? Insulin-positive single cells and cell clusters are lost before large islets during disease development. Insulin-positive single cells and cell clusters might be more susceptible to destruction in type 1 diabetes.

Indexed as

Diabetes Mellitus, Type 1InsulinInsulin-Secreting CellsIslets of LangerhansAdolescentAdultAgedAutoantibodiesChildChild, PreschoolFemaleHumansMaleMiddle AgedYoung AdultAutoantibodiesInsulin

Identifiers

PMID40705030
PMCPMC12585168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.